MetLife (MET) Stock Price & Analysis

MET$102.65+0.78 +0.77%
Insurance - LifeLarge CapValue Stock
Compare
Market cap$64.51BEnterprise value$60.19BRevenue (TTM)$82.29BMarket positionTop 25%

Score

50
Neutral
Value
60
Quality
45
Growth
44

AI Analysis

Snapshot

MetLife is a mixed profile at 50/100 — Value 60, Growth 44, Quality 45. Under the hood: P/E 25.6, rich vs its own history, plus revenue compounding ~4% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

60
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

44
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

45
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

MetLife, Inc. (MET) last printed $102.65. Equity value is $64.51B. Trailing earnings multiple 12.58. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$60.53B$62.31B$67.94B$69.62B$67.89B$63.37B$67.97B$67.71B$69.94B$77.08B

About

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

MetLife (MET) Stock Price & Analysis

MET price $102.65 +0.78 +0.77%

Ticker
MET
Price
$102.65
Change
+0.78 +0.77%
Market cap
$64.51B
P/E
12.58
Forward P/E
9.45
Dividend yield
2.28%
Beta
0.77
Sector
Financial Services
Industry
Insurance - Life
Stocklytics score
50
Value
60
Quality
45
Growth
44

Stocklytics score rationale: value 60, quality 45, growth 44.

AI Score 70. MetLife, Inc. has a solid market capitalization of approximately $63.97 billion and a price of $100.67, but its price-to-earnings ratio of about 25.6 suggests it may be overvalued relative to earnings

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener